September 19, 2020

You can use these same tactics to earn more customers.

Free Book Preview Ultimate Guide to Social Media Marketing

This book takes readers through a 360-degree perspective of social media marketing in businesses.

6 min read

Opinions expressed by Entrepreneur contributors are their own.

Scott Greenberg’s Wealthy Franchisee: Game-Changing Steps to Becoming a Thriving Franchise Superstar will be released via Entrepreneur Press on November 17. It can be preodered via Amazon and Barnes & Noble.

Politicians must do more than serve. They also have to sell. They’ve got to get the job before they can do it. Then they have to keep it. Right now, President Donald Trump and Vice President are actively selling themselves. Their campaigns are using powerful tactics designed to earn more votes. You can use these same tactics to earn more customers.

In his treatise entitled Rhetoric written around

It’s now been several months since companies first implemented their COVID-19 crisis response initiatives. Although in many parts of the world the virus continues to present serious health and economic challenges, company leaders must balance such urgencies with the need to take a longer-term view of their company’s prospects. To better understand this dynamic, PwC recently conducted a CEO Panel SurveyPDF, asking nearly 700 CEOs how their company’s business model will change after the pandemic. Their responses spoke volumes about how the future of work is likely to evolve.

As the leaders of small private firms and US$1 billion-plus public companies, representing a diverse cross section of industries, countries, and regions, these CEOs make the decisions that will redefine how and where work gets done — with implications for untold numbers of employees. The survey revealed that CEOs’ plans focus on three key areas: to become more digital

Beginning Monday, importers need to furnish proof of 35 per cent value addition in goods from the country of origin to claim duty concession under (FTAs).

Without that, they will not get benefits, said a finance ministry official.

While the move is aimed at plugging duty evasion through routing exports to India under FTAs, industry fears it will result in a compliance burden.

According to the official, just a certificate by the exporter would not suffice. It will be the importer’s responsibility to ensure value addition has been done.

A provision was incorporated into the Customs Act during the budget session of Parliament in February this year, on verifying rules of origin of under FTAs. The rules in implementing this were issued last month. The Customs department will now step up its inspection

Shares of pharmaceutical companies were on a roll on Friday, with the S&P BSE Healthcare index surging over 3 per cent to hit a record on the back of positive flow.

Twelve stocks, including Dr Reddy’s Laboratories, Laurus Labs, Cipla, Biocon, Divi’s Laboratories, FDC, Granules India and Apollo Hospitals scaled their respective records, while eight other stocks — Lupin, Cadila Healthcare, Natco Pharma, Stride Pharma, Neuland Labs, Lincoln Pharma and Hikal — hit their respective 52-week highs on the BSE.

The S&P BSE Healthcare index, the top gainer among sectoral indices, rose 3.5 per cent to close at 20,405 points, as compared to 0.34 per cent decline in the Sensex. The healthcare index hit high of 20,294 in intra-day.

In a positive development for Lupin and Cipla, Perrigo has announced a voluntary recall of its albuterol sulphate inhalation